Tag
Tag: Immuno-oncology
The Most Important Battle in Gene Editing: CRISPR versus TALEN
Could This Parisian Biotech Startup’s Cancer Treatment Compete With Merck and Novartis?
FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s
Meet the CEO of the Other Big Biotech Acquisition Target in 2017
Infographic: All You Need to Know About Checkpoint Inhibitors
German Biotech Raises Record $270M Series A for Individualized Cancer Therapies
Dutch and US Biotechs Team Up Against HPV-related Cancer
Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment
Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK
Merck and Pfizer’s Checkpoint Inhibitor Fails to Treat Gastric Cancer
